Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ueda Seiyaku is a Japanese pharmaceutical company primarily focused on the development and manufacture of active pharmaceutical ingredients (APIs) and chemical intermediates. Founded in 1947 and headquartered in Toyama, Japan, the company provides custom synthesis and contract manufacturing services (CMO/CDMO) to the global pharmaceutical industry. Their technical expertise includes complex chemical processes such as high-pressure reactions, low-temperature synthesis, and hazardous material handling. Ueda Seiyaku operates manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, supporting drug production from clinical development through to commercial supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ueda.